This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
CD2_BENIGN_CONNSOFT_LOWERLIMB
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
891 |
4. Check minimum number of eventsNone |
891 |
5. Include endpointsNone |
891 |
6. Filter based on genotype QC (FinnGen only) |
869 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi/textus mollis coxae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 869 | 530 | 339 |
| Unadjusted period prevalence (%) | 0.18 | 0.19 | 0.16 |
| Median age at first event (years) | 48.78 | 47.64 | 50.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 891
- Matched controls
- 8910
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
16384.0
307.7
635
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
16.4
172.3
155
113
21504
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Extremitatis inferioris (regione glutaea inclusa)
+∞
136.0
127
*
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
26.1
67.1
47
19
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
17.9
65.7
54
32
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
10.6
62.1
70
71
2153C
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,HERMOPERÄINEN]
+∞
54.8
52
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
8.8
53.3
69
84
NHR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of ankle or foot
123.9
44.2
47
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
13.7
39.3
37
28
2153A
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]
+∞
37.8
36
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
50.1
36.0
43
9
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
9.2
31.8
39
44
2153X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]
+∞
30.4
29
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
48.8
27.6
33
7
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
9.4
24.8
30
33
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
5.7
24.4
46
84
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
23.0
20.5
29
13
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
16.9
19.7
31
19
WX320
NOMESCO Finland
Spinalanesthesy
2.1
19.6
258
1473
9474
FHL
Soft tissue tumor removal (subcutaneous tumor 9736 skin tumor 9733)
30.7
16.2
21
7
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.1
14.9
26
44
ZXE00
NOMESCO Finland
One hour or less
1.7
13.2
354
2471
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.9
13.1
29
61
M67.4
ICD-10 Finland
Ganglion
2.6
13.0
76
304
NHM99
NOMESCO Finland
Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot
10.7
12.8
24
23
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.2
12.1
32
78
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
12.1
78
328
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
4.2
11.7
31
76
NHM10
NOMESCO Finland
Fasciotomy of ankle or foot
13.1
10.7
18
14
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.2
10.7
28
68
D21.9
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue, unspecified
16.3
10.4
16
10
9271
FHL
Hallux surgery
4.0
10.4
29
74
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
32.9
10.3
13
*
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
7.6
10.2
23
31
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
9.7
318
2295
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
9.6
65
280
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
17.8
9.4
14
8
N03AX16
ATC
[U] pregabalin
1.7
9.4
212
1390
2153B
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,LIHASKUDOSPERÄ]
+∞
9.4
9
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.4
9.1
33
101
ZXA00
NOMESCO Finland
Right side
1.6
9.1
237
1612
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
7.6
9.0
20
27
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
8.9
92
472
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
8.8
82
404
SPAT1153
SPAT
Removal of sutures
1.6
8.8
274
1946
J01DB01
ATC
cefalexin; oral
1.7
8.4
714
6302
NH1DG
NOMESCO Finland
Ankle and foot very extensive MRI examination with high intensity magnet
90.9
8.4
9
*
NH3CG
NOMESCO Finland
Extensive MRI of foot
9.6
8.3
16
17
M79.6
ICD-10 Finland
Pain in limb
1.5
7.8
357
2740
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
7.8
381
2966
N03AX12
ATC
[U] gabapentin; oral
1.7
7.6
148
929
7354A
ICD-9 Finland
Acquired deformities of toe, Other hammer toe (acquired)
12.0
7.6
13
11
XX2RW, ,
NOMESCO Finland
6.2
7.6
19
31
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.6
359
2773
NF3AA
NOMESCO Finland
Femur X-ray examination
3.4
7.6
27
82
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.5
243
1728
S18
ICPC
Laceration/cut
1.5
7.4
381
2990
2153D
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Lower limb, including hip[ALARAAJAN BENIGNI PEHMYTKUDOSKASVAIN,MUU]
+∞
7.3
7
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
7.4
7.2
16
22
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
7.2
112
659
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
30.3
7.2
9
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
6.9
297
2240
D18.0
ICD-10 Finland
Haemangioma, any site
3.4
6.9
24
72
C08CA10
ATC
nilvadipine; oral
3.7
6.8
21
58
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
22.7
6.7
9
*
SPAT1312
SPAT
General health counselling
1.5
6.6
256
1885
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.9
6.6
80
434
7340A
ICD-9 Finland
Flat foot[PES PLANUS]
70.3
6.4
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.3
212
1513
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
6.3
78
426
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
5.6
6.3
17
31
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
3.3
6.3
23
71
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
6.3
292
2229
S19
ICPC
Skin injury other
2.5
6.3
37
150
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
3.4
6.0
21
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
136
747
1.97
10.91
3.4
3.3
—
—
—
0
0
52
198
2.73
9.84
1.5
1.3
—
—
—
0
0
630
5419
1.56
8.06
4.9
4.1
12.16
12.15
mm/h
0.01
578
5001
44
174
2.61
7.78
1.5
1.6
4368.72
16464.80
e6/l
2.17
25
128
434
3489
1.48
7.45
6.2
5.9
27.38
27.67
%
0.21
407
3289
645
5645
1.52
7.00
8.5
7.4
79.08
77.85
u/l
0.22
603
5306
790
7286
1.74
6.48
16.6
14.0
19.31
23.50
mg/l
4.02
656
5745
422
3451
1.42
6.22
6.0
5.6
58.33
57.44
%
0.83
394
3250
20
58
3.50
6.03
2.0
1.4
28.87
33.34
%
0.16
13
38
376
3026
1.42
5.99
2.5
2.3
76.63
76.78
nmol/l
0.03
331
2706
805
7499
1.76
5.89
18.2
16.1
139.54
139.66
mmol/l
0.64
782
7291
806
7515
1.76
5.83
18.4
16.3
3.97
3.97
mmol/l
0.00
785
7294
407
3334
1.41
5.81
14.0
14.7
1.23
1.23
inr
0.05
149
962
638
5657
1.45
5.76
4.2
4.0
14.97
14.80
pmol/l
0.98
560
5133
739
6749
1.56
5.76
5.1
4.8
1.86
2.07
mu/l
0.57
660
6174
320
2517
1.42
5.74
3.0
3.4
2.37
2.35
mmol/l
0.90
262
2213
245
1874
1.42
5.02
2.8
2.6
352.25
6468.75
umol/l
7.15
208
1644
174
1255
1.48
4.85
1.3
1.3
24.24
32.95
iu/ml
0.79
51
415
168
1205
1.49
4.81
1.3
1.3
11.25
13.16
u/ml
0.13
65
457
23
85
2.75
4.71
1.9
1.5
66.46
64.05
%
0.09
13
60
448
3815
1.35
4.67
5.8
6.1
11.39
11.07
umol/l
0.23
416
3618
745
6898
1.49
4.60
15.0
12.9
81.41
81.02
ml/min/173m2
0.18
641
5665
247
1940
1.38
4.24
5.5
4.0
0.00
0.01
estimate
1.08
104
674
406
3441
1.33
4.22
2.5
2.6
—
—
—
0
0
282
2278
1.35
4.02
2.7
2.5
56.02
60.69
u/l
0.94
253
2105
722
6697
1.41
3.93
5.9
5.7
39.63
39.86
mmol/mol
0.30
649
6203
818
7792
1.61
3.73
12.1
10.2
26.51
25.95
u/l
0.33
788
7515
480
4213
1.30
3.70
8.7
9.0
4.24
4.09
e9/l
0.75
425
3700
356
3009
1.30
3.61
2.1
2.0
95.52
95.68
pmol/l
0.02
183
1542
483
4251
1.30
3.61
5.0
4.7
6.68
6.68
mmol/l
0.01
460
3975
419
3624
1.29
3.56
7.3
6.7
1.23
1.21
mmol/l
2.06
330
3102
87
583
1.55
3.44
5.8
3.8
1.22
1.23
mmol/l
0.38
78
510
385
3307
1.29
3.40
7.1
5.8
1.22
1.21
mmol/l
1.58
340
3023
78
515
1.56
3.29
1.5
1.6
—
—
—
0
0
194
1521
1.35
3.29
3.0
2.5
4.93
6.11
e6/l
0.74
177
1367
330
2788
1.29
3.29
3.9
3.6
30.58
54.18
ng/l
0.99
221
1940
28
136
2.09
3.25
3.1
3.6
57.96
58.59
%
0.10
28
136
17
66
2.61
3.22
1.3
1.3
2215.33
163327.52
e6/l
—
9
44
27
131
2.09
3.15
2.8
3.3
3.93
4.31
e9/l
0.49
27
131
271
2242
1.30
3.15
4.4
3.8
12.72
9.32
mg/mmol
0.50
159
1408
310
2611
1.29
3.13
3.5
3.1
—
—
—
0
0
843
8134
1.68
3.08
24.1
20.7
40.03
40.10
%
0.10
790
7612
843
8139
1.66
3.01
24.1
20.6
4.48
4.48
e12/l
0.07
822
7910
843
8141
1.66
2.98
24.3
20.7
134.96
134.92
g/l
0.03
830
8020
273
2276
1.29
2.96
3.5
3.2
7.26
7.47
mmol/l
0.32
214
1912
264
2195
1.29
2.92
3.3
3.1
43.45
98.86
e6/l
0.80
212
1692
842
8135
1.64
2.89
24.1
20.6
255.28
250.45
e9/l
1.24
822
7931
262
2185
1.28
2.82
2.4
2.1
164.63
241.43
u/l
1.16
245
2069
173
1367
1.33
2.77
2.1
1.7
1091.01
1189.45
nmol/l
0.83
118
1024
36
205
1.79
2.69
1.6
1.6
—
—
—
0
0
358
3113
1.25
2.69
5.2
4.6
35.65
35.65
g/l
0.00
333
2908
0
69
0.00
2.61
0.0
1.6
—
—
—
0
0
679
6363
1.28
2.56
17.5
16.8
14.72
14.89
%
0.34
668
6260
408
3614
1.24
2.55
4.6
3.7
0.03
0.00
estimate
0.39
106
671
124
947
1.36
2.49
6.8
5.5
1.02
1.03
mmol/l
0.17
114
866
402
3579
1.22
2.34
5.6
5.1
0.00
0.00
estimate
0.50
107
690
145
1145
1.32
2.33
2.6
2.4
14.02
13.09
umol/l
0.90
133
1061
747
7112
1.31
2.33
4.7
4.5
5.94
5.94
mmol/l
0.00
666
6470
524
4799
1.22
2.28
5.5
4.5
61.88
3383.44
e6/l
—
8
81
187
1536
1.28
2.23
1.8
1.7
466.26
27760688.02
pmol/l
1.46
150
1268
401
3581
1.22
2.23
4.6
3.7
0.00
0.00
estimate
0.50
108
735
238
2015
1.25
2.20
3.2
3.0
0.35
0.47
e6/l
0.27
191
1522
19
94
2.04
2.17
2.3
1.6
34.16
32.61
pg
1.09
19
94
769
7371
1.32
2.12
5.1
4.9
2.76
2.76
mmol/l
0.07
693
6786
7
175
0.40
2.05
1.0
1.5
—
—
—
0
0
9
32
2.83
2.00
2.4
2.9
45200.00
38740.78
ug/l
—
9
32
316
2780
1.21
2.00
4.9
3.9
—
—
—
0
0
78
576
1.39
1.96
3.2
2.5
64.67
65.88
ml/min/173m2
0.09
30
236
12
51
2.37
1.95
2.2
1.8
24.36
20.84
nmol/l
0.27
12
46
124
983
1.30
1.95
2.9
2.4
24.20
22.40
%
0.67
99
843
24
135
1.80
1.93
1.9
1.6
—
—
—
0
0
33
207
1.62
1.82
1.4
1.2
—
—
—
0
0
25
146
1.73
1.79
1.7
2.6
15.26
15.94
%
—
10
77
113
896
1.30
1.79
8.9
7.2
—
—
—
0
0
36
232
1.57
1.78
1.7
1.7
—
—
—
0
0
79
597
1.35
1.74
3.6
3.7
106.76
82.87
ng/l
0.51
63
530
129
1046
1.27
1.72
2.8
2.4
2.44
2.35
g/l
0.95
117
974
522
4850
1.18
1.71
3.1
3.0
48.58
47.08
u/l
0.15
486
4532
273
2399
1.20
1.71
3.2
3.2
39.29
31.49
u/l
0.47
262
2288
7
161
0.43
1.68
1.0
1.4
—
—
—
0
0
7
161
0.43
1.68
1.0
1.4
—
—
—
0
0
7
161
0.43
1.68
1.0
1.4
—
—
—
0
0
7
161
0.43
1.68
1.0
1.4
—
—
—
0
0
238
2069
1.21
1.67
5.2
4.8
1.81
2.68
ug/l
2.49
205
1844
723
6927
1.23
1.66
4.1
3.9
1.35
1.29
mmol/l
1.47
649
6333
80
611
1.34
1.66
2.5
2.5
3.90
7.65
ug/l
2.68
61
539
195
1666
1.22
1.63
4.5
4.2
21.23
21.35
%
0.04
85
784
5
14
3.59
1.61
1.0
1.4
—
—
—
0
0
751
7231
1.25
1.61
4.6
4.4
4.66
4.67
mmol/l
0.18
685
6690
144
1194
1.25
1.60
1.4
1.4
—
—
—
0
0
747
7191
1.24
1.59
4.6
4.3
1.45
1.48
mmol/l
1.07
677
6615
34
224
1.54
1.56
1.7
1.5
0.06
0.09
iu/ml
—
10
40
494
4590
1.17
1.56
3.1
3.0
—
—
—
0
0
8
33
2.44
1.54
2.5
2.2
—
—
—
0
0
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
12
59
2.05
1.44
1.2
1.1
—
81.83
—
0
6
350
3183
1.16
1.42
2.9
2.8
133.36
124.01
ug/l
0.35
314
2936
30
198
1.53
1.39
1.2
1.2
—
10.26
—
0
33
88
701
1.28
1.38
2.4
2.0
359.27
370.58
nmol/l
0.21
79
641
38
267
1.44
1.32
1.9
1.8
—
—
—
0
0
40
284
1.43
1.32
2.2
2.0
3.43
2.56
ug/l
0.13
33
255
161
1380
1.20
1.31
3.2
3.0
2.49
2.45
mmol/l
3.04
139
1207
27
177
1.54
1.30
1.3
1.3
—
—
—
0
0
24
153
1.58
1.30
1.3
2.2
137.41
128.24
g/l
1.18
17
120
236
2094
1.17
1.30
3.4
3.0
1185.10
1205.53
ng/l
0.04
192
1778
34
235
1.46
1.29
1.1
1.2
—
—
—
0
0
8
158
0.50
1.25
1.5
1.7
—
—
—
0
0
10
49
2.05
1.22
1.0
1.2
—
—
—
0
0
105
869
1.24
1.21
2.6
2.2
124.23
129.19
ug/g
0.05
84
692
40
289
1.40
1.21
1.9
1.9
—
—
—
0
0
162
1406
1.19
1.16
1.5
1.4
2.47
2.43
g/l
0.09
101
846
0
34
0.00
1.16
0.0
2.0
—
—
—
0
0
0
34
0.00
1.16
0.0
2.0
—
—
—
0
0
75
601
1.27
1.15
3.0
3.0
65.55
66.82
g/l
0.80
64
549
0
35
0.00
1.15
0.0
2.0
—
—
—
0
0
186
1637
1.17
1.13
1.3
1.3
2.17
1.40
u/ml
0.24
58
443
33
234
1.43
1.12
1.1
1.2
—
—
—
0
0
32
226
1.43
1.11
3.4
3.8
39.94
80.11
mg/l
0.75
20
181
32
226
1.43
1.11
3.4
3.8
53.24
29.46
mg/l
0.62
20
182
96
796
1.23
1.11
5.5
4.0
229.10
240.41
u/l
0.83
86
756
101
842
1.23
1.11
3.0
2.5
9.13
7.47
umol/l
0.39
84
726
51
391
1.32
1.09
2.9
2.7
0.16
0.21
e6/l
0.26
51
382
147
1280
1.18
1.02
1.4
1.5
—
—
—
0
0
7
35
2.01
1.00
1.1
2.1
0.26
0.21
e9/l
—
7
30
58
461
1.28
0.98
3.6
3.6
1.35
1.85
mmol/l
0.29
45
348
33
241
1.38
0.98
1.4
1.9
—
—
—
0
0
26
182
1.44
0.97
2.6
1.6
—
—
—
0
0
23
157
1.48
0.97
1.0
1.2
—
25.15
—
0
13
7
37
1.90
0.94
1.9
2.3
—
—
—
0
0
7
37
1.90
0.94
1.0
2.1
461.14
731.13
e6/l
—
7
30
27
196
1.39
0.85
1.2
1.2
—
2.47
—
0
23
137
1207
1.16
0.84
3.0
2.9
0.63
0.78
ug/l
2.14
78
780
8
46
1.75
0.82
1.3
1.5
1.56
1.56
g/l
—
8
46
8
46
1.75
0.82
1.4
1.4
—
—
—
0
0
16
105
1.53
0.82
1.3
1.1
53.86
85.82
iu/ml
—
7
22
70
584
1.22
0.80
2.7
3.0
135.19
202.48
ng/l
1.15
61
536
181
1634
1.14
0.79
2.1
1.7
1.24
1.13
mg/l
0.15
120
1246
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
202
1838
1.13
0.78
2.5
2.1
3.18
3.09
mg/l
0.20
165
1566
54
440
1.24
0.78
4.2
3.3
4.35
4.56
pmol/l
0.80
47
381
0
28
0.00
0.76
0.0
1.1
—
208.74
—
0
28
10
59
1.70
0.76
1.5
2.5
—
—
—
0
0
80
681
1.19
0.76
2.1
2.1
0.22
0.21
g/l
0.15
75
641
13
83
1.57
0.75
1.4
1.3
—
—
—
0
0
9
55
1.64
0.73
1.3
1.6
0.77
0.99
g/l
—
9
55
5
25
2.01
0.72
3.8
4.7
—
—
—
0
0
7
40
1.76
0.71
1.1
2.9
705.71
1067.15
u/ml
—
7
40
16
109
1.48
0.71
1.1
1.1
—
—
—
0
0
33
257
1.29
0.69
1.5
1.8
—
—
—
0
0
53
438
1.22
0.69
2.0
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
28
1.79
0.66
1.4
2.6
154.40
116.50
%
—
5
28
7
44
1.60
0.65
6.6
3.8
—
—
—
0
0
191
1757
1.11
0.62
1.6
1.5
20.46
20.73
nmol/l
0.09
158
1495
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
19
140
1.36
0.58
2.4
1.8
192.84
217.11
pmol/l
0.45
19
132
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
371.36
—
0
14
132
1195
1.12
0.58
2.1
1.9
—
—
—
0
0
39
319
1.23
0.58
1.8
2.0
1.35
1.53
g/l
0.72
29
286
57
485
1.19
0.57
2.6
2.3
11.93
12.69
nmol/l
0.33
52
431
58
676
0.85
0.57
3.6
2.3
27.02
34.57
u/l
1.67
49
568
6
36
1.67
0.56
5.5
1.6
—
—
—
0
0
6
36
1.67
0.56
5.5
1.6
—
—
—
0
0
23
296
0.77
0.56
1.3
1.5
—
—
—
0
0
6
37
1.63
0.55
1.2
1.0
—
—
—
0
0
6
38
1.58
0.54
1.2
6.2
—
35.20
—
0
10
135
1232
1.11
0.52
2.6
2.6
1.73
1.21
e6/l
0.64
86
703
28
224
1.26
0.51
3.0
2.1
10287.00
3764.84
u/l
0.39
11
93
35
420
0.83
0.48
2.2
1.9
—
—
—
0
0
44
373
1.19
0.48
1.0
1.0
—
—
—
0
0
11
76
1.45
0.48
2.2
2.2
—
—
—
0
0
17
128
1.33
0.48
1.6
1.7
—
—
—
0
0
16
120
1.34
0.46
1.4
1.7
—
—
—
0
0
31
255
1.22
0.46
5.7
4.2
1.11
1.35
mmol/l
1.64
31
249
13
94
1.39
0.46
1.3
1.1
—
—
—
0
0
5
83
0.60
0.46
1.2
1.1
—
—
—
0
0
5
85
0.59
0.45
2.2
1.8
—
—
—
0
0
37
436
0.84
0.44
2.0
1.5
—
—
—
0
0
15
113
1.33
0.43
1.0
1.1
—
—
—
0
0
6
92
0.65
0.42
1.3
1.8
—
1872.00
—
0
5
83
748
1.12
0.42
3.7
4.3
35.73
28.16
ug/l
0.10
67
627
5
32
1.57
0.42
1.2
1.1
1919.00
1710.75
miu/ml
—
5
32
8
57
1.41
0.42
1.1
1.1
—
—
—
0
0
8
57
1.41
0.42
1.1
1.1
—
—
—
0
0
8
58
1.38
0.41
1.1
1.1
—
—
—
0
0
8
58
1.38
0.41
1.1
1.1
—
—
—
0
0
8
58
1.38
0.41
1.1
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
8
61
1.31
0.39
1.1
1.8
—
—
—
0
0
24
196
1.23
0.39
2.0
1.8
37.96
39.51
nmol/l
0.16
24
187
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
125
1159
1.09
0.38
2.7
2.8
2.21
2.71
e6/l
0.40
74
634
10
72
1.39
0.37
2.5
3.9
—
—
—
0
0
22
180
1.23
0.36
1.1
1.1
—
—
—
0
0
5
76
0.66
0.36
2.2
1.9
—
—
—
0
0
91
835
1.10
0.35
1.4
1.7
1.57
1.47
%
0.51
81
730
6
43
1.40
0.35
1.8
1.8
7.60
7.66
mmol/l
—
6
43
89
817
1.10
0.34
7.9
7.5
1.66
1.32
mmol/l
0.35
74
650
204
1939
1.07
0.34
1.8
1.6
1.49
1.38
mmol/l
0.86
161
1632
6
45
1.34
0.33
1.7
1.3
5.68
8.11
u/l
—
6
35
6
46
1.31
0.33
1.5
1.4
74.50
76.63
umol/l
—
6
46
98
906
1.09
0.33
5.6
4.5
31.62
32.09
%
0.16
63
618
11
83
1.33
0.32
14.1
7.3
8.32
7.44
mmol/l
0.31
11
67
14
110
1.28
0.32
1.3
1.3
—
—
—
0
0
14
110
1.28
0.32
1.1
1.5
—
—
—
0
0
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
212
1.18
0.30
1.9
2.5
0.42
0.35
u/ml
0.33
17
118
28
240
1.17
0.30
1.5
1.4
—
—
—
0
0
30
260
1.16
0.29
4.0
2.5
9.07
10.41
g/l
0.82
21
234
124
1167
1.07
0.28
3.2
3.1
0.82
0.82
mmol/l
0.15
110
1098
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
26
224
1.17
0.27
1.2
1.3
118.42
275.42
miu/ml
—
10
110
44
395
1.12
0.27
1.1
1.3
—
—
—
0
0
56
510
1.10
0.27
1.3
1.2
70.51
142.01
iu/ml
2.19
21
208
17
203
0.83
0.26
1.4
1.5
—
—
—
0
0
10
127
0.78
0.25
1.2
1.7
—
—
—
0
0
10
127
0.78
0.25
1.2
1.7
—
—
—
0
0
143
1359
1.06
0.25
3.7
3.9
253.88
397.91
ng/l
0.48
105
1063
18
151
1.20
0.25
3.4
3.2
0.83
0.83
nmol/l
0.03
12
121
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
13
106
1.23
0.23
1.2
1.5
—
—
—
0
0
13
107
1.22
0.21
1.1
1.1
0.49
3.43
u/ml
—
6
53
5
42
1.19
0.21
1.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
12
98
1.23
0.21
1.2
1.4
—
—
—
0
0
12
98
1.23
0.21
1.2
1.4
—
—
—
0
0
5
43
1.16
0.21
1.0
1.6
—
—
—
0
0
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.5
—
0.59
—
0
8
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.2
2.23
1.94
mmol/l
—
6
49
12
99
1.22
0.19
1.2
1.4
—
—
—
0
0
14
165
0.85
0.19
1.1
1.2
5.21
3.79
mmol/l
0.83
14
155
16
137
1.17
0.19
1.3
1.2
—
—
—
0
0
65
609
1.07
0.18
11.0
7.2
9.74
9.71
mmol/l
0.01
56
576
11
132
0.83
0.18
1.1
1.2
22.07
41.72
u/l
0.61
11
114
31
341
0.91
0.17
2.1
1.8
—
—
—
0
0
23
205
1.13
0.17
1.9
2.4
3.65
3.61
g/l
0.05
23
199
21
236
0.89
0.17
2.3
2.8
—
—
—
0
0
31
282
1.10
0.17
3.9
2.4
7.35
7.36
g/l
0.01
22
257
31
282
1.10
0.17
3.9
2.4
3.81
3.55
g/l
0.18
22
257
31
282
1.10
0.17
3.9
2.4
—
—
—
0
0
12
101
1.19
0.16
1.2
1.4
—
—
—
0
0
12
101
1.19
0.16
1.2
1.4
—
—
—
0
0
27
244
1.11
0.16
4.1
2.7
0.84
0.99
g/l
0.07
16
218
25
225
1.11
0.16
3.8
2.6
38.38
38.08
g/l
0.10
16
200
8
71
1.13
0.16
3.0
3.3
20.38
61.75
u/ml
—
8
71
83
790
1.06
0.16
1.5
2.0
—
—
—
0
0
6
80
0.75
0.15
2.2
2.2
—
—
—
0
0
181
1758
1.04
0.15
2.5
2.3
—
—
—
0
0
12
102
1.18
0.15
1.2
1.3
0.62
0.58
nmol/l
0.14
12
94
9
82
1.10
0.15
1.1
1.8
—
—
—
0
0
164
1601
1.03
0.11
5.1
4.1
1.02
1.02
kg/l
0.18
22
218
68
653
1.04
0.10
4.0
3.2
2.29
2.03
mmol/l
0.22
60
532
5
44
1.14
0.10
2.2
2.3
—
152.60
—
0
5
10
114
0.88
0.09
1.1
1.5
—
—
—
0
0
74
714
1.04
0.09
1.5
1.9
—
—
—
0
0
5
48
1.04
0.09
1.2
1.4
124.48
163.12
pmol/l
—
5
48
5
48
1.04
0.09
1.0
1.1
13.80
11.71
u/l
—
5
42
17
155
1.10
0.09
1.1
1.4
—
—
—
0
0
12
134
0.89
0.08
1.6
1.8
—
—
—
0
0
6
56
1.07
0.08
2.0
1.9
—
—
—
0
0
6
57
1.05
0.08
1.3
1.4
—
—
—
0
0
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
32
338
0.94
0.08
5.1
3.1
24.93
24.24
mmol/l
0.71
32
328
41
429
0.95
0.08
4.8
3.0
123.41
126.54
g/l
0.42
41
421
7
68
1.03
0.08
1.0
1.0
—
—
—
0
0
23
245
0.94
0.07
1.5
1.4
—
—
—
0
0
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
9
84
1.07
0.07
1.2
1.5
—
—
—
0
0
9
84
1.07
0.07
1.2
1.5
—
—
—
0
0
28
265
1.06
0.07
4.1
2.5
2.90
2.98
g/l
0.18
19
240
10
89
1.12
0.07
1.0
1.4
308.20
383.05
pmol/l
—
10
80
8
93
0.86
0.06
1.0
1.1
—
—
—
0
0
11
99
1.11
0.06
1.2
1.4
—
—
—
0
0
20
212
0.94
0.05
1.3
1.3
—
—
—
0
0
21
222
0.94
0.05
1.2
1.5
335.75
285.59
ug/g
0.35
12
138
12
128
0.94
0.02
1.2
1.5
—
—
—
0
0
14
148
0.95
0.02
1.2
1.4
—
—
—
0
0
14
148
0.95
0.02
1.2
1.4
—
—
—
0
0
19
198
0.96
0.02
1.1
1.1
0.63
5.97
u/ml
—
6
23
11
103
1.07
0.02
1.2
1.7
—
—
—
0
0
21
203
1.04
0.01
4.3
2.7
0.00
0.00
g/l
-0.00
16
188
21
217
0.97
0.01
4.3
2.7
0.00
0.02
g/l
0.50
16
202
28
286
0.98
0.00
1.1
1.7
2.31
3.38
mg/l
0.83
15
220
14
144
0.97
0.00
1.1
1.5
—
—
—
0
0
17
166
1.02
0.00
1.3
1.4
—
—
—
0
0
10
98
1.02
0.00
1.1
1.0
—
—
—
0
0
83
835
0.99
0.00
2.0
1.8
—
—
—
0
0
13
128
1.02
0.00
1.2
1.2
338.43
268.09
u/ml
—
7
76
20
198
1.01
0.00
1.4
1.2
—
—
—
0
0
84
843
1.00
0.00
2.0
1.8
—
—
—
0
0
19
187
1.02
0.00
2.7
2.3
140.72
97.00
ug/min
—
9
112
14
141
0.99
0.00
1.3
1.5
—
—
—
0
0
18
185
0.97
0.00
1.2
1.7
—
—
—
0
0
18
185
0.97
0.00
1.2
1.2
441.17
491.87
mg/l
0.46
18
173
5
53
0.94
0.00
1.0
1.1
237.60
220.20
mg/l
—
5
46
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
63
630
1.00
-0.00
1.7
1.7
—
—
—
0
0
18
180
1.00
-0.00
1.4
1.7
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
8.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.1
35.80
39.86
mg/l
—
5
46
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
-0.00
1.0
1.3
—
—
—
0
0
7
76
0.92
-0.00
1.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_LOWERLIMB – Benign neoplasm: Connective and other soft tissue of lower limb, including hip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).